Design Therapeutics Ratios (2020-2026) | DSGN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
EBT Margin (Quarter)
EBIT Margin (Quarter)
EBITDA Margin (Quarter)
Operating Margin (Quarter)
Net Margin (Quarter)
FCF Margin (Quarter)
Efficiency
Assets Average (Quarter)	408.50M	402.75M	395.45M	384.68M	373.37M	361.25M	347.85M	332.94M	318.19M	305.75M	294.76M	284.22M	274.19M	265.61M	256.86M	244.78M	230.18M	217.33M	218.99M	228.32M
Equity Average (Quarter)	404.80M	396.58M	386.85M	376.22M	363.74M	349.05M	334.12M	320.06M	304.81M	290.88M	281.32M	273.62M	265.40M	256.85M	247.28M	235.01M	220.48M	206.38M	206.11M	215.28M
Invested Capital (Quarter)	401.60M	391.56M	382.13M	370.31M	357.16M	340.94M	327.31M	312.82M	296.80M	284.96M	277.69M	269.56M	261.24M	252.45M	242.10M	227.92M	213.04M	199.72M	212.50M	218.05M
Leverage & Solvency
Equity Ratio (Quarter)	0.99	0.98	0.98	0.98	0.97	0.96	0.96	0.96	0.95	0.95	0.96	0.97	0.97	0.96	0.96	0.96	0.96	0.94	0.94	0.95
Valuation
Enterprise Value (Quarter)	-402.84M	-357.77M	-384.06M	-371.22M	-359.38M	-344.23M	-330.39M	-315.39M	-303.09M	-290.94M	-281.80M	-270.69M	-261.02M	-254.07M	-245.48M	-229.67M	-216.28M	-205.97M	-219.84M	-222.82M
Return Ratios
Return on Sales (Quarter)
Return on Capital Employed (Quarter)	-4.84%	-7.19%	-9.18%	-11.48%	-14.06%	-16.91%	-20.05%	-23.43%	-27.06%	-28.11%	-27.42%	-25.60%	-23.67%	-23.55%	-25.11%	-28.92%	-33.84%	-37.83%	-38.59%	-36.10%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Design Therapeutics Ratios (2020-2026) | DSGN

Create an account

Sign In

Reset Password